Cargando…

Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome

Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudek, Jan, Cheng, I‐Fen, Chowdhury, Arpita, Wozny, Katharina, Balleininger, Martina, Reinhold, Robert, Grunau, Silke, Callegari, Sylvie, Toischer, Karl, Wanders, Ronald JA, Hasenfuß, Gerd, Brügger, Britta, Guan, Kaomei, Rehling, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734842/
https://www.ncbi.nlm.nih.gov/pubmed/26697888
http://dx.doi.org/10.15252/emmm.201505644
_version_ 1782412983527276544
author Dudek, Jan
Cheng, I‐Fen
Chowdhury, Arpita
Wozny, Katharina
Balleininger, Martina
Reinhold, Robert
Grunau, Silke
Callegari, Sylvie
Toischer, Karl
Wanders, Ronald JA
Hasenfuß, Gerd
Brügger, Britta
Guan, Kaomei
Rehling, Peter
author_facet Dudek, Jan
Cheng, I‐Fen
Chowdhury, Arpita
Wozny, Katharina
Balleininger, Martina
Reinhold, Robert
Grunau, Silke
Callegari, Sylvie
Toischer, Karl
Wanders, Ronald JA
Hasenfuß, Gerd
Brügger, Britta
Guan, Kaomei
Rehling, Peter
author_sort Dudek, Jan
collection PubMed
description Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome.
format Online
Article
Text
id pubmed-4734842
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47348422016-02-09 Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome Dudek, Jan Cheng, I‐Fen Chowdhury, Arpita Wozny, Katharina Balleininger, Martina Reinhold, Robert Grunau, Silke Callegari, Sylvie Toischer, Karl Wanders, Ronald JA Hasenfuß, Gerd Brügger, Britta Guan, Kaomei Rehling, Peter EMBO Mol Med Research Articles Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome. John Wiley and Sons Inc. 2015-12-23 2016-02 /pmc/articles/PMC4734842/ /pubmed/26697888 http://dx.doi.org/10.15252/emmm.201505644 Text en © 2015 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution 4.0 (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Dudek, Jan
Cheng, I‐Fen
Chowdhury, Arpita
Wozny, Katharina
Balleininger, Martina
Reinhold, Robert
Grunau, Silke
Callegari, Sylvie
Toischer, Karl
Wanders, Ronald JA
Hasenfuß, Gerd
Brügger, Britta
Guan, Kaomei
Rehling, Peter
Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title_full Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title_fullStr Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title_full_unstemmed Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title_short Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
title_sort cardiac‐specific succinate dehydrogenase deficiency in barth syndrome
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734842/
https://www.ncbi.nlm.nih.gov/pubmed/26697888
http://dx.doi.org/10.15252/emmm.201505644
work_keys_str_mv AT dudekjan cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT chengifen cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT chowdhuryarpita cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT woznykatharina cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT balleiningermartina cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT reinholdrobert cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT grunausilke cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT callegarisylvie cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT toischerkarl cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT wandersronaldja cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT hasenfußgerd cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT bruggerbritta cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT guankaomei cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome
AT rehlingpeter cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome